Wegovy is a prescription-only, once‑weekly injectable pen featuring semaglutide—a GLP‑1 receptor agonist that mimics natural gut hormones to curb appetite, slow stomach emptying, and promote a lasting sense of fullness. Designed for adults with obesity (BMI ≥ 30) or overweight individuals (BMI ≥ 27 with related health conditions), Wegovy delivers clinically supported weight loss when paired with healthy diet and lifestyle adjustments

This convenient, pre‑filled injection pen allows a gradual dosage escalation—from a 0.25 mg starter dose to a 2.4 mg maintenance dose—supported by pharmacist-guided medical oversight. Common side effects are typically mild and transient, including nausea, headache, or injection-site discomfort; serious adverse events are rare but require prompt attention.

Available in the UK through Synergy Pharmacy, each order follows a face-to-face medical consultation before approval for safe, discreet home delivery https://synergypharmacys.co.uk..../wegovy-semaglutide-